GEN Restaurant Group signs LOI to sell 47 US restaurants to Chubby Group for $100 million
Bitget2026/10/14 12:32- GEN Restaurant Group signed a binding LOI with Chubby Group to sell operations at 47 U.S. restaurants for $100 million.
- GEN will retain the GEN brand and its Korean CPG business, keeping about three restaurants for training and R&D support.
- Deal aims to cut roughly $160 million of lease liabilities, add a term note receivable, and enable GEN to eliminate outstanding debt.
- Chubby will run a four-phase, 12-month takeover; GEN keeps operating profits until each site transitions.
- GEN can convert any unpaid term note balance into Chubby equity at a $1.5 billion valuation; closing targeted within 30 days.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.